There are two industry investors who know quite a lot about Mesoblast.
One supplies them with cells, has done for years and stands to gain a lot when Mesoblast succeeds across multiple fronts, Lonza. Perhaps not an industry investor per se.
The other is IQVIA who have had quite literally first look at almost all Mesoblast trial data, another closely related business started out as their strategic investment arm, that is NovaQuest.
There are two industry investors who know quite a lot about...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.40 |
Change
0.045(3.33%) |
Mkt cap ! $1.592B | |||
| Open | High | Low | Value | Volume |
| $1.35 | $1.42 | $1.33 | $3.802M | 2.753M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 23940 | $1.39 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.40 | 22571 | 2 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |